CPC A61N 1/20 (2013.01) [A61B 5/0022 (2013.01); A61B 5/02 (2013.01); A61B 5/0205 (2013.01); A61B 5/02405 (2013.01); A61B 5/0533 (2013.01); A61B 5/08 (2013.01); A61B 5/1495 (2013.01); A61B 5/14542 (2013.01); A61B 5/4519 (2013.01); A61B 5/4836 (2013.01); A61B 5/6824 (2013.01); A61B 5/6828 (2013.01); A61B 5/7257 (2013.01); A61N 1/025 (2013.01); A61N 1/0452 (2013.01); A61N 1/0476 (2013.01); A61N 1/205 (2013.01); A61N 1/36003 (2013.01); A61N 1/36014 (2013.01); A61N 1/36034 (2017.08); G16H 10/60 (2018.01); G16H 20/30 (2018.01); A61B 5/021 (2013.01); A61B 5/0816 (2013.01); A61B 5/24 (2021.01); A61B 5/4824 (2013.01); A61B 2503/10 (2013.01); A61B 2562/046 (2013.01)] | 20 Claims |
1. A method of determining level of efficiency in a muscle comprising:
applying a first electrical current and a second electrical current with a stimulator via a first set of electrodes of an electrode array to a first location on a muscle, wherein the first electrical current acts as a carrier frequency and the second electrical current is a pulsed direct current in the frequency range between 5 hz and 20,000 hz with a pulse waveform that stimulates an action potential of nerves connected to the muscle to identify a first level of discomfort at the first location on the muscle;
applying the first electrical current and the second electrical current with the stimulator via a second set of electrodes of the electrode array to a second location at the muscle to identify a second level of discomfort at the second location at the muscle; and
comparing the first level of discomfort from the first location to the second level of discomfort from the second location at the muscle and determining whether the first location or the second location had a higher level of discomfort for tracking muscle efficiency progress during therapy of the muscle.
|